TOR1B and glioma: The results indicated that high expression of TOR1B is a risk factor affecting patient OS (HR > 1) in six types of tumors: Breast Invasive Carcinoma (BRCA), Glioblastoma Multiforme and Lower Grade Glioma (GBMLGG), Lower Grade Glioma (LGG), Acute Myeloid Leukemia (LAML), and Adrenocortical Carcinoma (ACC) (Fig. 2A, Supplementary Material 3).